|
On November 12, 2003, shareholders of Biogen Inc. (BGEN) will vote concerning a proposed merger with IDEC Pharmaceuticals
Corporation (IDPH). If the merger is approved, the combined company will be renamed to “BIOGEN IDEC INC” and the trading symbol
will become “BIIB”. Each share of BGEN common stock will be converted into the right to receive 1.15 BIIB common shares. The merger is expected
to become effective on or about November 13, 2003.
Please view the attached Corporate Events Alert Notice for more information.
Thank you.
|